2011
DOI: 10.4161/hv.7.7.15511
|View full text |Cite
|
Sign up to set email alerts
|

Summary of effectiveness and impact of rotavirus vaccination with the oral pentavalent rotavirus vaccine: A systematic review of the experience in industrialized countries

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
51
2

Year Published

2012
2012
2021
2021

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 67 publications
(56 citation statements)
references
References 43 publications
(64 reference statements)
3
51
2
Order By: Relevance
“…Despite these drugs are not subsidized by the government, recent studies have estimated a significant decrease in rotavirus hospitalizations in Spain since their use became more widespread in 2008. [10][11][12][13] Other industrialized countries have already shown a reduction in hospital admissions after 1 to 2 y of a complete immunization schedule, [14][15][16] with the vaccine remaining effective up to 3 y after the last dose. 17,18 The aim of our research is to describe the burden borne by hospitals due to community-acquired rotavirus in CLM and its …”
Section: Introductionmentioning
confidence: 99%
“…Despite these drugs are not subsidized by the government, recent studies have estimated a significant decrease in rotavirus hospitalizations in Spain since their use became more widespread in 2008. [10][11][12][13] Other industrialized countries have already shown a reduction in hospital admissions after 1 to 2 y of a complete immunization schedule, [14][15][16] with the vaccine remaining effective up to 3 y after the last dose. 17,18 The aim of our research is to describe the burden borne by hospitals due to community-acquired rotavirus in CLM and its …”
Section: Introductionmentioning
confidence: 99%
“…16 Rotavirus vaccination in countries with established vaccination programmes has consistently and significantly reduced the incidence of rotavirus gastroenteritis (RVGE) and associated hospitalizations, emergency department visits and outpatient/physician office visits in the United States (US), Europe and Australia. [17][18][19][20] Belgium introduced rotavirus vaccination in November 2006, with an uptake of 85% in the first year 21 and 89% in the second year.…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, no available evidence suggests that either rotavirus diarrhea in US and many other developed nations without significant increase in risk of intussusception. [10][11][12][13][14] Likewise, promising efficacy of rotavirus vaccines was also shown in developing countries. [15][16][17] However, the efficacy was 10-50% lower in developing-country than in developed country settings 15,[18][19][20] and therefore efforts to strengthen healthcare systems must also accompany vaccine introduction.…”
Section: Overview Of Available Rotavirus Vaccinesmentioning
confidence: 99%